Abstract
Purpose
The effect of existing anti-cancer therapies is based mainly on the stimulation of apoptosis in cancer cells. Here, we have demonstrated the ability of a catalytically-reactive nanoparticle-based complex of cytochrome c with cardiolipin (Cyt-CL) to induce the apoptosis and killing of cancer cells in a monolayer cell culture.
Methods
Cyt-CL nanoparticles were prepared by complexing CytC with different molar excesses of CL. Following characterization, cytotoxicity and apoptosis inducing effects of nanoparticles were investigated. In an attempt to identify the anticancer activity mechanism of Cyt-CL, pseudo-lipoxygenase and lipoperoxidase reaction kinetics were measured by chemiluminescence.
Results
Using chemiluminescence, we have demonstrated that the Cyt-CL complex produces lipoperoxide radicals in two reactions: by decomposition of lipid hydroperoxides, and by lipid peroxidation under the action of H2O2. Antioxidants inhibited the formation of lipid radicals. Cyt-CL nanoparticles, but not the CytC alone, dramatically enhanced the level of apoptosis and cell death in two cell lines: drug-sensitive (A2780) and doxorubicin-resistant (A2780-Adr). The proposed mechanism of the cytotoxic action of Cyt-CL involves either penetration through the cytoplasm and outer mitochondrial membrane and catalysis of lipid peroxidation reactions at the inner mitochondrial membrane, or/and activation of lipid peroxidation within the cytoplasmic membrane.
Conclusions
Here we propose a new type of anticancer nano-formulation, with an action based on the catalytic action of Cyt-CL nanoparticles on the cell membrane and and/or mitochondrial membranes that results in lipid peroxidation reactions, which give rise to activation of apoptosis in cancer cells, including multidrug resistant cells.
Similar content being viewed by others
Abbreviations
- Bcl-2:
-
B-cell/lymphoma 2
- BCL:
-
Bovine heart cardiolipin
- CytC:
-
Cytochrome c
- Cyt-CL:
-
Complex of cytochrome с with cardiolipin
- IMM and OMM:
-
Outer and inner mitochondrial membranes
- MDR:
-
Multidrug resistance
- PDI:
-
Polydispersity index
- TOCL:
-
1,1′,2,2′-Tetraoleoyl cardiolipin
- PBS:
-
10 mM NaH2PO4-Na2HPO4 (pH = 7.4)
References
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–57.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456–62.
Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305(5684):626–9.
Horvath SE, Daum G. Lipids of mitochondria. Prog Lipid Res. 2013;52(4):590–614.
Daum G, Vance JE. Import of lipids into mitochondria. Prog Lipid Res. 1997;36(2–3):103–30.
Daum G. Lipids of mitochondria. Biochim Biophys Acta. 1985;822(1):1–42.
Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, et al. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry-Us. 2006;45(15):4998–5009.
Vladimirov YA, Proskurnina EV, Izmailov DY, Novikov AA, Brusnichkin AV, Osipov AN, et al. Cardiolipin activates cytochrome c peroxidase activity since it facilitates H(2)O(2) access to heme. Biochemistry (Mosc). 2006;71(9):998–1005.
Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2005;1(4):223–32.
Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood. 1997;89(6):1845–53.
Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005;55(3):178–94.
Lopez J, Tait SW. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015;112(6):957–62.
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348(6299):334–6.
Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335(6189):440–2.
Mendez J, Morales Cruz M, Delgado Y, Figueroa CM, Orellano EA, Morales M, et al. Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells. Mol Pharm. 2014;11(1):102–11.
Santra S, Kaittanis C, Perez JM. Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm. 2010;7(4):1209–22.
Kim SK, Foote MB, Huang L. The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials. 2012;33(15):3959–66.
Vladimirov YA, Proskurnina EV, Alekseev AV. Molecular mechanisms of apoptosis. Structure of cytochrome c-cardiolipin complex. Biochemistry (Mosc). 2013;78(10):1086–97.
Vladimirov YA, Nol’ YT, Volkov VV. Protein-lipid nanoparticles that determine whether cells will live or die. Crystallogr Rep+. 2011;56(4):553–9.
de Kruijff B, Cullis PR. Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta. 1980;602(3):477–90.
Bergstrom CL, Beales PA, Lv Y, Vanderlick TK, Groves JT. Cytochrome c causes pore formation in cardiolipin-containing membranes. Proc Natl Acad Sci U S A. 2013;110(16):6269–74.
Puchkov MN, Vassarais RA, Korepanova EA, Osipov AN. Cytochrome c produces pores in cardiolipin-containing planar bilayer lipid membranes in the presence of hydrogen peroxide. Biochim Biophys Acta. 2013;1828(2):208–12.
Marchenkova MA, Dyakova YA, Tereschenko EY, Kovalchuk MV, Vladimirov YA. Cytochrome c complexes with cardiolipin monolayer formed under different surface pressure. Langmuir. 2015;31(45):12426–36.
Tyurina YY, Kini V, Tyurin VA, Vlasova II, Jiang J, Kapralov AA, et al. Mechanisms of cardiolipin oxidation by cytochrome c: relevance to pro- and antiapoptotic functions of etoposide. Mol Pharmacol. 2006;70(2):706–17.
Basova LV, Kurnikov IV, Wang L, Ritov VB, Belikova NA, Vlasova II, et al. Cardiolipin switch in mitochondria: shutting off the reduction of cytochrome c and turning on the peroxidase activity. Biochemistry-Us. 2007;46(11):3423–34.
Belikova NA, Jiang J, Tyurina YY, Zhao Q, Epperly MW, Greenberger J, et al. Cardiolipin-specific peroxidase reactions of cytochrome C in mitochondria during irradiation-induced apoptosis. Int J Radiat Oncol Biol Phys. 2007;69(1):176–86.
Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, et al. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med. 2009;46(11):1439–53.
Jiang J, Huang Z, Zhao Q, Feng W, Belikova NA, Kagan VE. Interplay between bax, reactive oxygen species production, and cardiolipin oxidation during apoptosis. Biochem Biophys Res Commun. 2008;368(1):145–50.
Kagan VE, Chu CT, Tyurina YY, Cheikhi A, Bayir H. Cardiolipin asymmetry, oxidation and signaling. Chem Phys Lipids. 2014;179:64–9.
Fabisiak JP, Tyurina YY, Tyurin VA, Kagan VE. Quantification of selective phosphatidylserine oxidation during apoptosis. Methods Mol Biol. 2014;1105:603–11.
Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, et al. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med. 2004;37(12):1963–85.
Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF, et al. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 2000;477(1–2):1–7.
Tyurin VA, Balasubramanian K, Winnica D, Tyurina YY, Vikulina AS, He RR, et al. Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA2. Cell Death Differ. 2014;21(5):825–35.
Izmailov D. PowerGraph: the powerfull software for data acquisition, visualization, processing and analysis 2003 [Available from: http://www.powergraph.ru/en/soft/.
Vladimirov YA, Sharov VS, Driomina ES, Reznitchenko AV, Gashev SB. Coumarin derivatives enhance the chemiluminescence accompanying lipid peroxidation. Free Radic Biol Med. 1995;18(4):739–45.
Iwase H, Sakurada K, Takatori T, Nagao M, Niijima H, Matsuda Y, et al. Calcium ions potentiate lipoxygenase activity of cytochrome c at the physiological pH. Biochem Biophys Res Commun. 1998;243(2):485–91.
Tuominen EK, Wallace CJ, Kinnunen PK. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J Biol Chem. 2002;277(11):8822–6.
Niv R, Assaraf YG, Segal D, Pirak E, Reiter Y. Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoprotein. Int J Cancer. 2001;94(6):864–72.
Minko T, Kopeckova P, Pozharov V, Kopecek J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release. 1998;54(2):223–33.
de Jong E, Winkel P, Poelstra K, Prakash J. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. PLoS One. 2011;6(9):e25192.
Vladimirov YA. Intrinsic (low-level) chemiluminescence. In: Punchard N, Kelly F, editors. Free Radicals: A Practical Approach, Practical Approach Series. editors ed. Oxford: Oxford University Press; 1996. p. 65–82.
Vladimirov YA. Intrinsic chemiluminescence of living tissues. In: Nohl H, Esterbauer H, Rice-Evans C, editors. Free radicals in the environment, medicine and toxicology. London: Richelieu Press; 1994. p. 345–73.
Vladimirov YA, Arroyo A, Taylor JM, Tyurina YY, Matsura T, Tyurin VA, et al. Quinolizin-coumarins as physical enhancers of chemiluminescence during lipid peroxidation in live HL-60 cells. Arch Biochem Biophys. 2000;384(1):154–62.
Belikova NA, Tyurina YY, Borisenko G, Tyurin V, Samhan Arias AK, Yanamala N, et al. Heterolytic reduction of fatty acid hydroperoxides by cytochrome c/cardiolipin complexes: antioxidant function in mitochondria. J Am Chem Soc. 2009;131(32):11288–9.
Sharov VS, Driomina ES, Vladimirov YA. Two processes responsible for chemiluminescence development in the course of iron-mediated lipid peroxidation. J Biolumin Chemilumin. 1996;11(2):91–8.
Izmailov DY, Bolevich SB, Proskurnina EV, Shishkanov SA, Vladimirova GA, Vladimirov YA. The mechanism and kinetics of the chemiluminescent reaction in the peroxidase-H2O2-luminol system in the presence of different antioxidants: the results of mathematical simulation. Free radical biology and medicine. 2016;in press.
Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6(5):513–9.
Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis. 2007;12(9):1543–68.
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275(5303):1129–32.
Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol. 2004;165(6):775–80.
Kapralov AA, Yanamala N, Tyurina YY, Castro L, Samhan-Arias A, Vladimirov YA, et al. Topography of tyrosine residues and their involvement in peroxidation of polyunsaturated cardiolipin in cytochrome c/cardiolipin peroxidase complexes. Biochim Biophys Acta. 2011;1808(9):2147–55.
Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955–61.
Sasaki H, Takada K, Terashima Y, Ekimoto H, Takahashi K, Tsuruo T, et al. Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2. Gynecol Oncol. 1991;41(1):36–40.
McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008;1785(2):96–132.
Mohell N, Alfredsson J, Fransson A, Uustalu M, Bystrom S, Gullbo J, et al. APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. Cell Death Dis. 2015;6:e1794.
Hoffsten PE, Hunter Jr FE, Gebicki JM, Weinstein J. Formation of "lipid peroxide" under conditions which lead to swelling and lysis of rat liver mitochondria. Biochem Biophys Res Commun. 1962;7:276–80.
Hunter Jr FE, Gebicki JM, Hoffsten PE, Weinstein J, Scott A. Swelling and lysis of rat liver mitochondria induced by ferrous ions. J Biol Chem. 1963;238:828–35.
Olenev VI, Suslova TB, Vladimirov YA. Comparative-study of different types of swelling of rat-liver mitochondria. Stud Biophys. 1976;58(2):147–61.
Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A. 2002;99(3):1259–63.
Shiratsuchi A, Osada S, Kanazawa S, Nakanishi Y. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem Biophys Res Commun. 1998;246(2):549–55.
Jiang J, Serinkan BF, Tyurina YY, Borisenko GG, Mi Z, Robbins PD, et al. Peroxidation and externalization of phosphatidylserine associated with release of cytochrome c from mitochondria. Free Radic Biol Med. 2003;35(7):814–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vladimirov, Y.A., Sarisozen, C., Vladimirov, G.K. et al. The Cytotoxic Action of Cytochrome C/Cardiolipin Nanocomplex (Cyt-CL) on Cancer Cells in Culture. Pharm Res 34, 1264–1275 (2017). https://doi.org/10.1007/s11095-017-2143-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-017-2143-1